tiprankstipranks
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market

Cognition Therapeutics (CGTX) Financial Statements

77 Followers

Cognition Therapeutics Financial Overview

Cognition Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.917; its P/E ratio is -2.08; Cognition Therapeutics is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -14.05M$ -8.13M$ -14.43M$ -4.72M$ -6.16M
EBITDA$ -13.99M$ -8.07M$ -14.37M$ -4.66M$ -6.10M
Net Income Common Stockholders$ -9.15M$ -8.14M$ -14.43M$ -4.73M$ -6.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.67M$ 29.92M$ 32.97M$ 37.19M$ 38.81M
Total Assets$ 38.85M$ 35.16M$ 38.77M$ 43.96M$ 45.41M
Total Debt$ 668.00K$ 694.00K$ 735.00K$ 774.00K$ 808.00K
Net Debt$ -34.00M$ -29.23M$ -32.23M$ -36.42M$ -38.00M
Total Liabilities$ 9.99M$ 10.69M$ 9.85M$ 9.57M$ 9.88M
Stockholders Equity$ 28.86M$ 24.47M$ 28.93M$ 34.39M$ 35.78M
Cash Flow-
Free Cash Flow$ -7.24M$ -5.49M$ -4.22M$ -3.71M$ -2.75M
Operating Cash Flow$ -7.24M$ -5.46M$ -4.16M$ -3.70M$ -2.71M
Investing Cash Flow-$ -30.00K$ -58.00K$ -18.00K$ -41.00K
Financing Cash Flow$ 11.99M$ 2.44M$ -3.00K$ 2.10M$ -10.00K
Currency in USD

Cognition Therapeutics Earnings and Revenue History

Cognition Therapeutics Debt to Assets

Cognition Therapeutics Cash Flow

Cognition Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis